No. 1684Independent rewrite deskUpdated September 12, 2026

Financial News
& Market Press Releases

MACROChubu Electric Power reportedly set to pull Hamaoka nuclear restart applicationsSep 12TSLAFord's Fathom targets 100,000 units in year one as Louisville prepares for Q1 productionSep 12MACROIsraeli-Lebanese talks set for State Department next weekSep 12EARNINGSCooper Rush named Atlanta Falcons' Week 1 starter as Tua Tagovailoa ruled out with oblique injurySep 11AAPLSiri bank scam: Apple voice assistant routed 82-year-old to fake American Express number, BBB warns of wider patternSep 11AMZNAnker Soundcore Liberty 5 Pro earbuds take first price cut as AirPods 5 arrives at the same tierSep 11ENERGYAugust inflation print keeps Fed rate hike in playSep 11REGULATORYNolan McLean in focus as Mets look to steal Subway Series win from YankeesSep 11MACROAugust CPI data sharpens the stakes for Warsh's inflation callSep 11DEALSAxogen pays $200m for BioCircuit Technologies to bring sutureless nerve repair in-houseSep 11MACROChubu Electric Power reportedly set to pull Hamaoka nuclear restart applicationsSep 12TSLAFord's Fathom targets 100,000 units in year one as Louisville prepares for Q1 productionSep 12MACROIsraeli-Lebanese talks set for State Department next weekSep 12EARNINGSCooper Rush named Atlanta Falcons' Week 1 starter as Tua Tagovailoa ruled out with oblique injurySep 11AAPLSiri bank scam: Apple voice assistant routed 82-year-old to fake American Express number, BBB warns of wider patternSep 11AMZNAnker Soundcore Liberty 5 Pro earbuds take first price cut as AirPods 5 arrives at the same tierSep 11ENERGYAugust inflation print keeps Fed rate hike in playSep 11REGULATORYNolan McLean in focus as Mets look to steal Subway Series win from YankeesSep 11MACROAugust CPI data sharpens the stakes for Warsh's inflation callSep 11DEALSAxogen pays $200m for BioCircuit Technologies to bring sutureless nerve repair in-houseSep 11

NewsDeals · TSLA

Ford's Fathom targets 100,000 units in year one as Louisville prepares for Q1 production

A first-year volume target of more than 100,000 units is the number in focus for Ford Motor Company (F) as the automaker prepares to launch the Fathom, a $30,000 electric pickup set for production at its Louisville, Kentucky plant in the first quarter of 2027. That figure would make the Fathom the first non-Tesla electric vehicle to move 100,000 units for a single U.S. model in one year. Customer orders are set to open in early 2027, the next confirmable milestone for the setup.

By Renata OstrowskiNewsroomSeptember 12, 20262 min readTSLA ·MS

Ford is targeting first-year volume of more than 100,000 units for its Fathom electric pickup, which would make it the first non-Tesla EV to move 100,000 units for a single U.S. model in one year.
The Fathom is a $30,000 electric pickup slated for production at Ford's Louisville, Kentucky plant in the first quarter of 2027, with customer orders opening in early 2027.
Ford is building the Fathom on a new Universal EV platform with a redesigned manufacturing process, an effort CEO Jim Farley has called a potential "Model T moment."
In Q2 2026 (reported July 28), Ford posted revenue of $48.3 billion (down 4% year over year) and a GAAP net loss of $1.3 billion, while adjusted EPS of $0.42 beat consensus.
Ford raised its full-year 2026 adjusted EBIT outlook for the second time to $10 billion to $11 billion, and its shares closed the last session at $14 with a consensus Moderate Buy rating.

The operational build

Ford is constructing the Fathom on a new Universal EV platform with a redesigned manufacturing process the company says is intended to dramatically lower costs. CEO Jim Farley has described the effort as a potential "Model T moment." The Louisville plant anchors the supply-side story: capacity commitments and the order-book opening in early 2027 will be the two near-term throughput signals investors can actually measure.

The Q2 2026 numbers, reported July 28, show where Ford's operations stand heading into the ramp. Revenue came in at $48.3 billion, down 4% year over year, as wholesale units fell 12% to 1.04 million. Adjusted EBIT rose to $2.5 billion from $2.1 billion and adjusted EPS of $0.42 beat consensus. The GAAP line ran to a net loss of $1.3 billion against a $36 million loss in Q2 2025.

Ford Model e was the weakest segment. Revenue fell 56% year over year to $1 billion as EV wholesale volumes dropped 53% to 28,000 vehicles, though the segment's EBIT loss narrowed to $919 million from $1.3 billion. Ford Pro faced aluminum supply constraints that compressed its margin to 9.7% from 12.3%, with revenue declining 5% to $17.8 billion. Ford Blue provided the counterweight: EBIT rose to $1.1 billion from $661 million on revenue up 1% to $26.1 billion.

Guidance and the analyst read

Ford raised its full-year adjusted EBIT outlook for the second time in 2026, now targeting $10 billion to $11 billion against the prior range of $8.5 billion to $10.5 billion. Adjusted free cash flow guidance moved to $6 billion to $7 billion from $5 billion to $6 billion. Capital expenditure guidance held at $9.5 billion to $10.5 billion.

Analysts project EPS of $1.86 for fiscal 2026, a 70.6% year-over-year increase, and $1.94 in fiscal 2027. Shares closed the last session at $14, up roughly 7% year to date and about 22% over the past 52 weeks, but still 21% below the 52-week high of $17.78 reached May 29, 2026. The stock trades at 7.88 times forward earnings, a discount to industry peers.

Morgan Stanley maintained Hold with a $14 price target last month. DBS Bank upgraded to Moderate Buy from Hold on August 11. The consensus across 23 analysts sits at Moderate Buy, with an average price target of $15.25 and a Street-high of $20. The order-book opening in early 2027 will supply the first hard demand number.

More from the Newsroom

All stories →

01Deals

Axogen pays $200m for BioCircuit Technologies to bring sutureless nerve repair in-house

A $200m all-cash agreement to acquire BioCircuit Technologies puts Florida-based Axogen in position to absorb NerveTape, the first sutureless peripheral nerve repair device to earn FDA clearance, with closing expected in Q4 2026. The deal…

Miles Broadbent2 min read

02Deals

MYI sets December ex-dividend date for USD 0.0555 monthly payout

A cash dividend of USD 0.0555 per share is in focus for MYI, with both the ex-dividend date and the record date set for December 11, 2026. Payment arrives December 22. The declared cadence is monthly.

Renata Ostrowski2 min read

03Deals

CTYLF sets ZAR 0.11 semi-annual dividend with October 2 ex-date

A cash dividend of ZAR 0.11 per share is in focus for CTYLF, declared on the company's semi-annual schedule. The ex-dividend date and record date both land on October 2, 2026, with the payment clearing on October 5.

Renata Ostrowski2 min read

Frequently asked

What is the Ford Fathom and when will it be produced?

The Fathom is a $30,000 electric pickup set for production at Ford's Louisville, Kentucky plant in the first quarter of 2027, with customer orders opening in early 2027.

Why is the 100,000-unit target significant?

Hitting more than 100,000 first-year units would make the Fathom the first non-Tesla electric vehicle to move 100,000 units for a single U.S. model in one year.

How did Ford's Model e (EV) segment perform in Q2 2026?

Ford Model e revenue fell 56% year over year to $1 billion as EV wholesale volumes dropped 53% to 28,000 vehicles, though its EBIT loss narrowed to $919 million from $1.3 billion.

What do analysts think of Ford stock?

The consensus across 23 analysts is Moderate Buy with an average price target of $15.25 and a Street-high of $20, with the stock closing the last session at $14.

How did Ford change its full-year 2026 guidance?

Ford raised its full-year adjusted EBIT outlook to $10 billion to $11 billion and its adjusted free cash flow guidance to $6 billion to $7 billion, while holding capital expenditure guidance at $9.5 billion to $10.5 billion.